COVID-19 and Disease Progression to the Severe Form: a Study on the Use of Monoclonal Antibodies Against SARS-CoV-2
Clinical trial NCT05268601 · COMPLETED
Trial details
- NCT number
- NCT05268601
- Sponsor
- University of Milano Bicocca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-10-14
- Primary completion
- 2023-12-22
- Enrollment
- 251
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.